EMA – Page 19 – Pharma.Tips

Requalification overdue during lifecycle management – preventing repeat validation findings

Managing Overdue Requalifications During Lifecycle Management in Pharma In a highly regulated environment like pharmaceutical manufacturing, keeping abreast of requalifications is crucial to maintaining compliance and ensuring operational effectiveness. When…

Inadequate worst-case selection during change control – regulatory deficiency risk

Addressing Inadequate Worst-Case Selection in Change Control Processes In the complex world of pharmaceutical manufacturing, one critical aspect that can lead to regulatory deficiencies is the inadequate selection of worst-case…

Inadequate worst-case selection during lifecycle management – risk-based validation alignment

Effective Strategies for Addressing Inadequate Worst-Case Selection in Lifecycle Management In pharmaceutical manufacturing, the importance of thorough validation during lifecycle management cannot be overstated. Inadequate worst-case selection can lead to…

CSV compliance weak during change control – CAPA and revalidation strategy

Addressing Weaknesses in CSV Compliance During Change Control: A Practical Playbook Change control is an essential process in pharmaceutical manufacturing that ensures all modifications are documented, evaluated, and implemented without…

Incomplete validation lifecycle during site expansion – regulatory deficiency risk

Managing the Risks of Incomplete Validation Lifecycles During Pharmaceutical Site Expansion The pharmaceutical industry is under constant pressure to expand operations, which often leads to the complexities associated with incomplete…

Validation gaps identified during lifecycle management – preventing repeat validation findings

Addressing Validation Fails Throughout the Lifecycle Management Process Validation gaps can pose significant challenges in pharmaceutical manufacturing and quality assurance, particularly during lifecycle management. Professionals in production, QC, QA, engineering,…

Management review ineffective during inspection readiness – QMS maturity gap analysis

“`html Addressing Ineffective Management Reviews During Inspection Readiness: A QMS Playbook In the dynamic environment of pharmaceutical manufacturing, it is critical that management reviews are both effective and efficient, particularly…

Poor QMS metrics during management review – building an inspection-resilient QMS

Tackling Poor QMS Metrics During Management Review: A Playbook for an Inspection-Resilient System Pharmaceutical organizations often face the challenge of poor quality management system (QMS) metrics during internal management reviews.…

Ineffective deviation management during integration of new sites – building an inspection-resilient QMS

Ineffective Deviation Management During New Site Integrations: Building a Resilient QMS Transitioning new manufacturing sites into an existing Quality Management System (QMS) often uncovers hidden inefficiencies, particularly in deviation management.…

Tag: EMA